Monday, June 10, 2013 | ||
08.30 - 10.00 | Concurrent Symposia S09 - S12 | |
S09. New therapeutic highlights in rare diseasesS09.1 Adaptive immunodeficiency and gene therapy treatment, Alain Fischer, France S09.2 Antisense therapy in SMA, Adrian Krainer, United States S09.3 Stem-cell gene therapy for the Wiskott-Aldrich Syndrome, Christoph Klein, Germany S10. Reproductive genetics and newborn screeningS10.1 Noninvasive whole genome sequencing, Stephen Quake, United States S10.2 New approaches in preimplantation screening, Dagan Wells, United Kingdom S10.3 Newborn screening; what is possible, what do we want?, Bridget Wilcken, Australia S11. Animal Models for Human DiseasesS11.1 Mice and Down Syndrome, Yann Hérault, France S11.2 Modelling human diseases in worm, Thorsten Hoppe, Germany S11.3 Modelling human diseases in flies, Bassem Hassan, Belgium S12. Judging our genesS12.1 The geneticist's perspective, Andrew Read, United Kingdom S12.2 Genetics in the courtroom: narrowing down the free-will compass? A social and ethical perspective, Mairi Levitt, United Kingdom S12.3 Narrowing down the free-will compass? A legal perspective, Amedeo Santosuosso, Italy | ||
08.30 - 10.00 | Educational Session 6 | |
ES6. Retinal dystrophies: news and viewsES6.1 Inherited retinal dystrophies: insights & challenges behind the rainbow, Frans P. M. Cremers, The Netherlands ES6.2 Inherited retinal disease - management and therapies, Andrew Webster, United Kingdom | ||
10.00 - 10.30 | Coffee Break, Free Poster Viewing, Exhibition | |
10.30 - 11.30 | Poster Viewing with Authors (Even poster numbers) | |
11.30 - 13.15 | Free Poster Viewing, Exhibition, Lunch | |
11.40 - 13.10 | Educational Session ES7-ES8 | |
ES7. NGS in the clinicES7.1 Introducing next generation technology to clinical scientists, Caroline Wright, United Kingdom ES7.2 Bioinformatic challenges of applying NGS in the clinic, Christian Gilissen, The Netherlands ES8. How to get published in the European Journal of Human Genetics (EJHG)GertJan B. van Ommen, The Netherlands, | ||
11.40 - 13.10 | Corporate Satellites | |
13.15 - 14.45 | Concurrent Sessions C08 - C14 | |
C08. Intellectual disability: Gene discovery and dysfunctionC09. Population-based sequencingC10. Genetic Counselling, Education and Public ServicesC11. Molecular mechanisms in tumorigenesisC12. Connective tissue disorders: Gene identificationC13. Neurodegenerative disorders: From gene discovery to therapyC14 Sensory disorders and Immunological disorders | ||
14.45 - 15.15 | Vitamin Break, Free Poster Viewing, Exhibition | |
| ||
15.15 - 16.45 | Workshops W10 - W14 | |
Workshop 10: Dysmorphology 2 (Dian Donnai & Jill Clayton-Smith) - View details | ||
15.15 - 16.45 | Corporate Satellites | |
16.45 - 17.15 | Coffee Break | |
17.15 - 18.45 | Concurrent Symposia S13 - S16 | |
S13. Stem cells and IPS cells in genetic diseasesS13.1 Human pluripotent stem cells for modeling genetic diseases, Oliver Brüstle, Germany S13.2 iPS for modelling diseases and drug screening : the example of Steinertmyotonic dystrophy, Cécile Martinat, France S13.3 IPS cells for targeted gene correction, Ludovic Vallier, United Kingdom S14. Chromosomal (in)stabilityS14.1 DNA repair and microcephaly, Mark O'Driscoll, United Kingdom S14.2 Consequences of balanced translocations in neurodevelopment, Cynthia Morton, United States S14.3 Chromosomal mosaicisms in aging and cancer, Jan Dumanski, Sweden S15. The interrelated world of drugs and genesS15.1 Drugs and genes - an overview, Ann Daly, United Kingdom S15.2 An immunological basis for pharmacogenetic associations in the MHC, James McCluskey, Australia S15.3 Genetic risk mirrors outcome of anti-TNF therapy in Multiple Sclerosis, Lars Fugger, United Kingdom S16. The expanding world of the primary ciliaS16.1 Extreme ciliary phenotypes, Tania Attie, France S16.2 Primary cilia -kidney disease - DNA Repair, Thomas Benzing, Germany S16.3 Moving into and inside cilia: the awesome power of diffusion, Maxence Nachury, United States | ||
17.15 - 18.45 | Educational Session 9 | |
ES9. Where do we come from?ES9.1 A genetics history of our species, Évelyne Heyer, France ES9.2 Tracing back geographic origine and phenotypes using genetic data, Manfred Kayser, The Netherlands | ||
20.00 | ESHG Congress Party |